Haineng Xu

Fudan University — China

Medicine · Health Sciences

21h-index1.9kcitations98works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiopharmaceutical Chemistry and Applications(37), Boron Compounds in Chemistry(18), Peptidase Inhibition and Analysis(18), Medical Imaging Techniques and Applications(17), PARP inhibition in cancer therapy(12)

Publications98 total

Engineered TIGIT‐Blockade Membrane Vesicles Synergize with Microwave Ablation to Mediate Liver Metastases Eradication
Advanced Science·2026Open Access
Abstract A133: Target clear cell ovarian cancers with ARID1A loss by combination inhibition of BRD4 and ATR
Molecular Cancer Therapeutics·2025
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR
Nature Communications·2025· 16 citedOpen Access
Clinical Analysis of Combining Probiotics with High-Dose Dual Therapy for Helicobacter pylori Eradication
Journal of Clinical and Nursing Research·2025Open Access
A Gsh-Consuming Polymeric Nanoparticles Drives Ferroptosis Amplification And Combines Chemotherapy to Enlarge Breast Cancer Treatment
SSRN Electronic Journal·2025Open Access
Capitalizing on the absence of TP53 mutations in low-grade serous and clear cell ovarian cancer with XPO1 inhibition
Gynecologic Oncology·2024
Effect of the mRNA decapping enzyme scavenger (DCPS) inhibitor RG3039 on glioblastoma
Journal of Translational Medicine·2024· 2 citedOpen Access
1461P Analysis of MET gene alterations in cfDNA samples from a phase II study of savolitinib in patients (pts) with MET-amplified gastroesophageal junction adenocarcinomas or gastric cancer (GEJ/GC)
Annals of Oncology·2024Open Access
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and CCNE1 amplified ovarian cancer
iScience·2024· 8 citedOpen Access
Supplementary Figure S6 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
2024Open Access
Supplementary Figure S7 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
2024Open Access
Supplementary Figure S1 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
2024Open Access
Supplementary Figure S4 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
2024Open Access
Supplementary Table S1 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
2024Open Access
Supplementary Figure S9 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
2024Open Access
Supplementary Table S3 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
2024Open Access
Supplementary Figure S11 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
2024Open Access
Supplementary Figure S6 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
2024Open Access
Supplementary Methods S1 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
2024Open Access
Supplementary Table S5 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
2024Open Access
page 1 of 5Next →

Frequent Co-authors

Fiona Simpkins(19), Hyoung Kim(18), Sarah B. Gitto(12), Eric J. Brown(11), Sushil Kumar(10), Sergey Medvedev(10), Benjamin Ferman(10), Margaret Whicker(10), Daniel J. Powell(9), Tianrun Liu(8), Gareth Davies(8), Krista Kinneer(8), Arthur Lewis(8), Srinivas Mamidi(8), Sergey Medvedev(8), Judith Anderton(8), E. Jessica Tang(8), Steven Coats(8), Robert W. Wilkinson(8), Erin George(7)